Free Trial
OTCMKTS:NHNKY

Nihon Kohden 11/8/2023 Earnings Report

Nihon Kohden logo
$11.08 -1.31 (-10.57%)
As of 02:52 PM Eastern

Nihon Kohden EPS Results

Actual EPS
$0.17
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nihon Kohden Revenue Results

Actual Revenue
$379.33 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nihon Kohden Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Nihon Kohden Earnings Headlines

NHNKY Nihon Kohden Corporation - Seeking Alpha
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.tc pixel
Nihon Kohden FY Net Y14.10B Vs Net Y17.03B
See More Nihon Kohden Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nihon Kohden? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nihon Kohden and other key companies, straight to your email.

About Nihon Kohden

Nihon Kohden (OTCMKTS:NHNKY) engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

View Nihon Kohden Profile

More Earnings Resources from MarketBeat